Document Detail

Pharmacological models of Parkinson's disease in rodents.
MedLine Citation:
PMID:  21913103     Owner:  NLM     Status:  In-Data-Review    
Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Despite the substantial progress that has been achieved, the precise mechanisms involved in the development of this disease are still not fully understood. The most common concepts relate to the genetic background and environmental/toxic effects. A number of model systems have been introduced, which mimic the human disease to varying extents. In this chapter, we introduce some of the most widely accepted protocols of the pharmacological models of Parkinson's disease.
Peter Klivenyi; Laszlo Vecsei
Related Documents :
12507683 - Future directions in research with presymptomatic individuals carrying the gene for hun...
21791453 - A stratified model for health outcomes in ankylosing spondylitis.
12952503 - Iometopane: (123)i beta-cit, dopascan injection, gpi 200, rti 55.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Methods in molecular biology (Clifton, N.J.)     Volume:  793     ISSN:  1940-6029     ISO Abbreviation:  Methods Mol. Biol.     Publication Date:  2011  
Date Detail:
Created Date:  2011-09-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9214969     Medline TA:  Methods Mol Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  211-27     Citation Subset:  IM    
Department of Neurology, University of Szeged, Szeged, Hungary,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Modeling focal cerebral ischemia in vivo.
Next Document:  Behavioral phenotyping of mouse models of neurodegeneration.